Visit JCR Japan
Visit JCR Japan
Home
Who we are
Innovation
Pipeline
Patients & families
Our commitment
Partnerships
Investors & media
Our products
Contact us
Reports
FY2025 first quarter results conference call
by JCR Pharmaceuticals
Notice regarding the completion of payment for the disposition of treasury stock as restricted stock compensation
by JCR Pharmaceuticals
Notice of resolutions passed at the 50th ordinary general meeting of shareholders
by JCR Pharmaceuticals
Matters concerning controlling shareholders (affiliated companies)
by JCR Pharmaceuticals
Notice regarding the disposition of treasury stock as restricted stock compensation
by JCR Pharmaceuticals
Other matters subject to measures for electronic provision when convening the 50th ordinary general meeting of shareholders
by JCR Pharmaceuticals
Notice of convocation of the 50th ordinary general meeting of shareholders
by JCR Pharmaceuticals
FY2024 results briefing session
Watch video (external)
by JCR Pharmaceuticals
FY2024 results briefing session script
by JCR Pharmaceuticals
[Delayed] Notice of recognition of gain on deferred income taxes
by JCR Pharmaceuticals
1
2
3
4
Privacy Preference Center
Privacy Preferences
